Yumiko Kanda
Meikai University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yumiko Kanda.
Biochimica et Biophysica Acta | 1978
Misayoshi Kumegawa; Taishin Takuma; Satoko Hosoda; Shiro Kunii; Yumiko Kanda
Effects of hormones on pepsinogen activity in mouse stomach were investigated by enzyme assay and electron microscopy. Administration of hydrocortisone alone to mice on days 5--10 increased the enzyme activity in the stomach to as much as 4.5-fold that of untreated mice and the increase was dose dependent. Thyroxine also evoked precocious differentiation of the stomach. The effects of thyroxine and hydrocortisone were additive. Injections of insulin had little effect when given alone, or in combination with other hormones. Injection of hydrocortisone alone or plus thyroxine also caused morphological differentiation of the chief cells in the stomach mucosa. Administration of thyroxine to mice on days 15--20 induced as much enzyme activity as that induced by hydrocortisone, but neither of these hormones had any effect when injected after day 23. These results suggest that besides hydrocortisone, thyroxine is also involved in differentiation of the stomach in mice for the first 20 days after birth and that the normal increase of pepsinogen activity in the stomach of mice during the late suckling period is brought about by serum glucocorticoids, possibly with thyroxine.
Toxicology reports | 2015
Hiroshi Sakagami; Chiyako Shimada; Yumiko Kanda; Osamu Amano; Masahiro Sugimoto; Sana Ota; Tomoyoshi Soga; Masaru Tomita; Akira Sato; Sei-ichi Tanuma; Koichi Takao; Yoshiaki Sugita
4H-1-benzopyran-4-ones (chromones) are important naturally-distributing compounds. As compared with flavones, isoflavones and 2-styrylchromones, there are only few papers of 3-styrylchromones that have been published. We have previously reported that among fifteen 3-styrylchromone derivatives, three new synthetic compounds that have OCH3 group at the C-6 position of chromone ring, (E)-3-(4-hydroxystyryl)-6-methoxy-4H-chromen-4-one (compound 11), (E)-6-methoxy-3-(4-methoxystyryl)-4H-chromen-4-one (compound 4), (E)-6-methoxy-3-(3,4,5-trimethoxystyryl)-4H-chromen-4-one (compound 6) showed much higher cytotoxicities against four epithelial human oral squamous cell carcinoma (OSCC) lines than human normal oral mesenchymal cells. In order to further confirm the tumor specificities of these compounds, we compared their cytotoxicities against both human epithelial malignant and non-malignant cells, and then investigated their effects on fine cell structures and metabolic profiles and cell death in human OSCC cell line HSC-2. Cytotoxicities of compounds 4, 6, 11 were assayed with MTT method. Fine cell structures were observed under transmission electron microscope. Cellular metabolites were extracted with methanol and subjected to CE-TOFMS analysis. Compounds 4, 6, 11 showed much weaker cytotoxicity against human oral keratinocyte and primary human gingival epithelial cells, as compared with HSC-2, confirming their tumor-specificity, whereas doxorubicin and 5-FU were highly cytotoxic to these normal epithelial cells, giving unexpectedly lower tumor-specificity. The most cytotoxic compound 11, induced the mitochondrial vacuolization, autophagy suppression followed by apoptosis induction, and changes in the metabolites involved in amino acid and glycerophospholipid metabolisms. Chemical modification of lead compound 11 may be a potential choice for designing new type of anticancer drugs.
Anticancer Research | 2007
Takashi Sekine; Juri Takahashi; Masayuki Nishishiro; Atsuhiro Arai; Hidetsugu Wakabayashi; Teruo Kurihara; Masaki Kobayashi; Ken Hashimoto; Hirotaka Kikuchi; Tadashi Katayama; Yumiko Kanda; Shiro Kunii; Noboru Motohashi; Hiroshi Sakagami
Anticancer Research | 1998
Satoh K; Yoshiteru Ida; Hosaka M; Hidetoshi Arakawa; Masako Maeda; Mariko Ishihara; Shiro Kunii; Yumiko Kanda; Toguchi M; Hiroshi Sakagami
Anticancer Research | 2009
Hiroshi Sakagami; Kaori Kishino; Osamu Amano; Yumiko Kanda; Shiro Kunii; Yoshiko Yokote; Hiroshi Oizumi; Takaaki Oizumi
Anticancer Research | 2006
Masahiro Sasaki; Masahiko Okamura; Atsushi Ideo; Jun Shimada; Fumika Suzuki; Mariko Ishihara; Hirotaka Kikuchi; Yumiko Kanda; Shiro Kunii; Hiroshi Sakagami
Anticancer Research | 2006
Risa Takeuchi; Hiroshi Hoshijima; Nagasaka H; Shahead Ali Chowdhury; Hirotaka Kikuchi; Yumiko Kanda; Shiro Kunii; Masami Kawase; Hiroshi Sakagami
in Vivo | 2006
Takashi Yamazaki; Atsushi Yamazaki; Yasushi Hibino; Shahead Ali Chowdhury; Yoshiko Yokote; Yumiko Kanda; Shiro Kunii; Hiroshi Sakagami; Hiroshi Nakajima; Jun Shimada
Anticancer Research | 2000
Hiroshi Terasaka; Tamura A; Fumitoshi Takayama; Kashimata M; Ohtomo K; Mamoru Machino; Seiichiro Fujisawa; Toguchi M; Yumiko Kanda; Shiro Kunii; Kaoru Kusama; Ishino A; Shigeru Watanabe; Satoh K; Takano H; Takahama M; Hiroshi Sakagami
in Vivo | 2014
Rene Garcia-Contreras; Rogelio J. Scougall-Vilchis; Rosalía Contreras-Bulnes; Yumiko Kanda; Hiroshi Nakajima; Hiroshi Sakagami